Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Canadian Lung Association Research Studentship

University of British Columbia

$19,000.00

Alternative metrics of sleep apnea severity derived from polysomnography

EF 2022-23

Résumé
Identifying novel useful metrics in the context of this common disease would result in a paradigm shift in clinical care; away from the predominately ‘one size fits all’ approach that relies on the AHI. Specifically, these metrics will help identify patients at high risk of adverse outcomes, who should be targeted for more aggressive OSA therapy and targeted risk factor management (more precision-care approach). Obstructive sleep apnea (OSA) affects approximately one billion adults globally and is characterized by repetitive upper airway collapse leading to fragmented sleep, hypoxemia, sympathetic activation, surges in blood pressure, cortical activation, vasoconstriction, and tachycardia. However, one major challenge is the inability to predict which OSA patients are particularly vulnerable as standard OSA severity metrics (e.g., apnea-hypopnea index- AHI) are not that helpful. Identifying high-risk patients would be clinically useful for targeting more aggressive clinical interventions. The overall goal is to develop alternative metrics of OSA severity derived from polysomnography (PSG) that can predict OSA-related adverse outcomes better than standard PSG metrics. Specifically, I will: 1) Determine which physiologic PSG signals are most affected by respiratory events, and which are most related to degree of event-related hypoxemia; 2) Using the data from Objective 1, I will develop novel physiologic metrics and assess whether they can predict outcomes better than standard metrics. We will leverage data from the CSCN databank which consists of over 2000 adults referred for suspected OSA with detailed phenotyping (>1600 have had PSG). For objective 1, PSG (EDF format) will be analyzed in MATLAB; for each event (i.e., apnea/hypopnea), we will determine the extent to which a variety of physiologic signals change (e.g. change in EEG power bands delta/theta/alpha/beta/gamma, heart rate response, dampening of the plethysmography signal). For each event, the area under the desaturation curve (HBEV) will be calculated form the SpO2 signal to determine degree of event related hypoxemia. For each subject, mixed effects models will be used to evaluate the association between HBEV and changes in signals (adjusting for confounders). For objective 2, we will examine the most promising signals from 1) to develop new metrics of OSA severity that would account for event-related changes in physiology (e.g. sum of changes in alpha power across events). The association between these metrics and outcomes (e.g. cognitive function, incident cardiovascular disease) will be ascertained, and compared to standard PSG metrics (AHI). OSA is an important and common lung disease. This research will improve care and health outcomes in these patients and is thus of significant relevance to the aims of the Lung Association.
Programme
Canadian Lung Association Research Studentship
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
476982
Name
Hajipour Mohammadreza
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Lung Association (Ottawa)
Prcname2
Special Cases
Projecttitle
Alternative metrics of sleep apnea severity derived from polysomnography
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$19,000
Cihrequipment2
$0
Programname2
Canadian Lung Association Research Studentship
Keyworddelim
Apnea-Hypopnea Index; Health Outcomes; Obstructive Sleep Apnea; Polysomnography; Signal Processing
Abstract
Identifying novel useful metrics in the context of this common disease would result in a paradigm shift in clinical care; away from the predominately ‘one size fits all’ approach that relies on the AHI. Specifically, these metrics will help identify patients at high risk of adverse outcomes, who should be targeted for more aggressive OSA therapy and targeted risk factor management (more precision-care approach). Obstructive sleep apnea (OSA) affects approximately one billion adults globally and is characterized by repetitive upper airway collapse leading to fragmented sleep, hypoxemia, sympathetic activation, surges in blood pressure, cortical activation, vasoconstriction, and tachycardia. However, one major challenge is the inability to predict which OSA patients are particularly vulnerable as standard OSA severity metrics (e.g., apnea-hypopnea index- AHI) are not that helpful. Identifying high-risk patients would be clinically useful for targeting more aggressive clinical interventions. The overall goal is to develop alternative metrics of OSA severity derived from polysomnography (PSG) that can predict OSA-related adverse outcomes better than standard PSG metrics. Specifically, I will: 1) Determine which physiologic PSG signals are most affected by respiratory events, and which are most related to degree of event-related hypoxemia; 2) Using the data from Objective 1, I will develop novel physiologic metrics and assess whether they can predict outcomes better than standard metrics. We will leverage data from the CSCN databank which consists of over 2000 adults referred for suspected OSA with detailed phenotyping (>1600 have had PSG). For objective 1, PSG (EDF format) will be analyzed in MATLAB; for each event (i.e., apnea/hypopnea), we will determine the extent to which a variety of physiologic signals change (e.g. change in EEG power bands delta/theta/alpha/beta/gamma, heart rate response, dampening of the plethysmography signal). For each event, the area under the desaturation curve (HBEV) will be calculated form the SpO2 signal to determine degree of event related hypoxemia. For each subject, mixed effects models will be used to evaluate the association between HBEV and changes in signals (adjusting for confounders). For objective 2, we will examine the most promising signals from 1) to develop new metrics of OSA severity that would account for event-related changes in physiology (e.g. sum of changes in alpha power across events). The association between these metrics and outcomes (e.g. cognitive function, incident cardiovascular disease) will be ascertained, and compared to standard PSG metrics (AHI). OSA is an important and common lung disease. This research will improve care and health outcomes in these patients and is thus of significant relevance to the aims of the Lung Association.
Competitiondate
202210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hajipour, Mohammadreza
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &Respiratory Hlth~ $19,000~ $0~